Alzheimer's Disease Clinical Trials in Austin, TX

12 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia	Early 1	University of Texas at Austin	<1 mi
Paper-Based and Smartphone-Based Memory Supports	N/A	Baylor University	<1 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease	Phase 2	Celgene	<1 mi
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD	Phase 3	Annovis Bio Inc.	<1 mi
Remotely-supervised Neuromodulation in PPA	N/A	University of Texas at Austin	<1 mi
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease	Phase 4	University of Texas at Austin	<1 mi
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia	N/A	University of Texas at Austin	<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	<1 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
[18F]PI-2620 Phase 3 Histopathological Study	Phase 3	Life Molecular Imaging Ltd	17 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)	Phase 3	Bristol-Myers Squibb	17 mi
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase	N/A	University of Alabama, Tuscaloosa	29 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.